Skip to main content

Table 1 Comparison of clinical parameters of acute stroke patients with positive thyroid autoantibody and those with negative thyroid autoantibody

From: Subclinical thyroid dysfunction and autoantibodies in acute ischemic and hemorrhagic stroke patients: relation to long term stroke outcome

Variables Thyroid autoantibody P value
Positive (N = 47) Negative (N = 91)
Age, years 64.17 ± 12.46 64.55 ± 10.3 0.85
Sex
 Male, n (%) 21 (45%) 39(43%) 0.82
 Female, n (%) 26 (55%) 52(57%)
SBP, mmHg 116.9 ± 12.5 118.43 ± 12.23 0.49
DBP, mmHg 76.2 ± 7.9 77.3 ± 9.2 0.49
TC, mmol/L 5.20 ± 1.12 5.26 ± 1.13 0.77
LDL-C, mmol/L 3.37 ± 0.57 3.31 ± 0.81 0.65
HDL-C, mmol/L 1.22 ± 0.36 1.17 ± 0.32 0.41
TG, (mg/dL) 138.8 ± 76.2 127.8 ± 62.42 0.58
Initial free T4 level (pmol/L) 13.7 ± 2.7 14.01 ± 2.4 0.49
Final free T4 level (pmol/L) 14.9 ± 3.2 14.4 ± 3.1 0.37
Free T3 level (pmol/L) 4.11 ± 0.75 4.19 ± 0.73 0.55
Initial TSH level (mIU/mL) 1.64 ± 1.08 1.62 ± 1.13 0.92
Final TSH level (mIU/mL) 3.98 ± 0.58 3.74 ± 0.69 0.04*
Type of stroke
 Ischemic infarction 34 (72%) 74 (81%)  
 Intracerebral hemorrhage 13 (28%) 17 (19%) 0.23
 NIHSS score at admission 10 ± 5 8 ± 2 0.001**
  1. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG triglycerides, T3 tri-iodothyronine, T4 thyroxin, TSH thyroid stimulating hormone, NIHSS National Institute of Health Stroke Scale
  2. Continuous data are represented in mean ± standard deviation; categorical data are represented in number and percentage
  3. **Highly significant